1. Home
  2. INSW vs NUVB Comparison

INSW vs NUVB Comparison

Compare INSW & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSW
  • NUVB
  • Stock Information
  • Founded
  • INSW 1999
  • NUVB 2018
  • Country
  • INSW United States
  • NUVB United States
  • Employees
  • INSW N/A
  • NUVB N/A
  • Industry
  • INSW Semiconductors
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • INSW Technology
  • NUVB Health Care
  • Exchange
  • INSW Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • INSW 2.3B
  • NUVB 2.4B
  • IPO Year
  • INSW N/A
  • NUVB N/A
  • Fundamental
  • Price
  • INSW $53.28
  • NUVB $7.97
  • Analyst Decision
  • INSW Strong Buy
  • NUVB Strong Buy
  • Analyst Count
  • INSW 1
  • NUVB 8
  • Target Price
  • INSW $48.00
  • NUVB $9.63
  • AVG Volume (30 Days)
  • INSW 502.5K
  • NUVB 11.3M
  • Earning Date
  • INSW 11-06-2025
  • NUVB 11-03-2025
  • Dividend Yield
  • INSW 5.44%
  • NUVB N/A
  • EPS Growth
  • INSW N/A
  • NUVB N/A
  • EPS
  • INSW 4.39
  • NUVB N/A
  • Revenue
  • INSW $770,036,000.00
  • NUVB $26,748,000.00
  • Revenue This Year
  • INSW N/A
  • NUVB $283.17
  • Revenue Next Year
  • INSW $7.43
  • NUVB $340.98
  • P/E Ratio
  • INSW $12.10
  • NUVB N/A
  • Revenue Growth
  • INSW N/A
  • NUVB 1137.19
  • 52 Week Low
  • INSW $27.20
  • NUVB $1.54
  • 52 Week High
  • INSW $55.18
  • NUVB $8.24
  • Technical
  • Relative Strength Index (RSI)
  • INSW 58.06
  • NUVB 80.85
  • Support Level
  • INSW $52.65
  • NUVB $6.51
  • Resistance Level
  • INSW $55.18
  • NUVB $7.50
  • Average True Range (ATR)
  • INSW 1.45
  • NUVB 0.62
  • MACD
  • INSW -0.18
  • NUVB 0.27
  • Stochastic Oscillator
  • INSW 42.64
  • NUVB 92.48

About INSW International Seaways Inc.

International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: